Skip to Content Facebook Feature Image

Archaeological site in Alaska that casts light on early Yup'ik life ravaged by ex-Typhoon Halong

News

Archaeological site in Alaska that casts light on early Yup'ik life ravaged by ex-Typhoon Halong
News

News

Archaeological site in Alaska that casts light on early Yup'ik life ravaged by ex-Typhoon Halong

2025-10-30 19:14 Last Updated At:19:20

JUNEAU, Alaska (AP) — A fragment of a mask that was preserved for hundreds of years in permafrost sat in the muck of a low tide in the western Alaska community of Quinhagak. Wooden spoons, toys, a fishing lure and other artifacts were strewn, in some cases for miles, along the beach.

The Yup'ik community near the edge of the Bering Sea was spared the widespread devastation wrought by the remnants of Typhoon Halong on its neighbors further west earlier this month. But it suffered a different kind of blow: The lashing winds and storm surge devoured dozens of feet of shoreline, disrupting a culturally significant archaeological site and washing away possibly thousands of unearthed artifacts.

About 1,000 pieces, including wooden masks and tools, were recovered in Quinhagak after the storm ravaged parts of southwest Alaska on Oct. 11 and 12. But many more pieces — perhaps up to 100,000 — were left scattered, said Rick Knecht, an archaeologist who has worked on the Nunalleq, or old village, project for 17 years. That's roughly the number of pieces previously recovered from the archaeological site.

Meanwhile, freezing temperatures and ice have settled into the region, stalling immediate efforts to find and recover more displaced artifacts on searches done by four-wheeler and foot.

Knecht called what happened a major loss. The site has yielded the world's largest collection of pre-contact Yup'ik artifacts. Much of what's known about Yup'ik life before outsiders arrived stems from the project, said Knecht, an emeritus senior lecturer in archaeology at the University of Aberdeen in Scotland.

“When there are holes or disturbances in the site, it’s like trying to read a book with holes in the pages. You're going to miss a few things,” he said. “And the bigger those holes are, the weaker the story gets. There’s a few holes in the book right now.”

While the name of the original village isn't known, it was attacked by another village and burned around 1650, he said. Knecht has worked with elders and others in Quinhagak to combine their traditional knowledge with the technology and techniques used by the archaeology teams to study the past together.

Quinhagak has about 800 residents, and subsistence food gathering is critically important to them.

The storm dispersed artifacts from a site long preserved by permafrost, Knecht said. A longstanding concern has been the threat that climate change — melting permafrost, coastal erosion, the potential for more frequent or stronger storms — has posed to the site, he said.

It poses risks to the community itself. Erosion threatens major infrastructure in Quinhagak, including a sewage lagoon, homes and fish camps. Thawing permafrost is also unsettling and undermining buildings, according to a 2024 report from the Alaska Native Tribal Health Consortium.

The excavation project itself began after artifacts began appearing on the beach around 2007. Part of the site that washed out had been excavated previously.

“There was a big chunk where we’d only gone about halfway down and left it for later because we prioritized parts of the site that were most at risk from marine erosion,” Knecht said.

When he left in July, there was a roughly 30-foot buffer to the sea. The storm took out the buffer and another 30 feet of the site, he said. It also left what Knecht described as piano-sized clumps of tundra on the tidal flats.

Knecht didn't recognize the site at first after Halong.

“I just drove right by it because all the landmarks I’m used to on the beach and at the site were gone or changed,” he said.

Work to preserve the rescued artifacts has included soaking the marine salts from the wood and placing the pieces in special chemicals that will help them hold together when they dry out, he said. If one were to just take one of the wooden artifacts off the beach and let them dry, they'd “crack to pieces, sometimes in a matter of hours.”

There is a lab at the museum in Quinhagak where the artifacts are kept.

Archaeologists hope to return to the site next spring for a “rescue excavation” of layers exposed by the storm, he said. In some ways, it feels like when teams saw the site in 2009: “We’ve got this raw site with artifacts popping off in every way,” he said. “So we’re starting from scratch again.”

The shore of Kuskokwim Bay on the Bering Sea is seen Monday, Oct. 27, 2025, near Kongiganak, Alaska. (AP Photo/Lindsey Wasson)

The shore of Kuskokwim Bay on the Bering Sea is seen Monday, Oct. 27, 2025, near Kongiganak, Alaska. (AP Photo/Lindsey Wasson)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Recommended Articles